Biodesix Inc. saw its stock price slashed in early trading Friday after the life-sciences company that specializes in developing tools to detect lung disease lowered its 2026 sales forecast.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.